UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

102: Parental newborn screening experience at a southeastern CF center

Journal of cystic fibrosis, 2021-11, Vol.20, p.S52

2021

Volltextzugriff (PDF)

104 Effect of acute systemic corticosteroids on clinical outcomes in cystic fibrosis pulmonary exacerbations

Journal of cystic fibrosis, 2023-10, Vol.22, p.S55-S55

2023

Volltextzugriff (PDF)

11 Examining antibiotic regimen spectrum and clinical outcomes of pulmonary exacerbation treatment

Journal of cystic fibrosis, 2023-10, Vol.22, p.S7-S7

2023

Volltextzugriff (PDF)

115 Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis – Cochrane review

Journal of cystic fibrosis, 2015-06, Vol.14, p.S86-S86

2015

Volltextzugriff (PDF)

117 Safety profile of levofloxacin inhalation solution from 3 controlled cystic fibrosis clinical trials

Journal of cystic fibrosis, 2015-06, Vol.14, p.S87-S87

2015

Volltextzugriff (PDF)

A 12-Year-Old Girl With Dyspnea and a Normal Chest Radiographic Finding

Chest, 2001-10, Vol.120 (4), p.1372-1376

2001

Volltextzugriff (PDF)

A 12-year-old girl with dyspnea and a normal chest radiographic finding. Hypersensitivity pneumonitis

Chest, 2001-10, Vol.120 (4), p.1372-1376

2001

Volltextzugriff (PDF)

128 Sex-based differences in cystic fibrosis pulmonary exacerbations: Subanalysis of the Standardized Treatment of Pulmonary Exacerbations-2 cohort

Journal of cystic fibrosis, 2022-10, Vol.21, p.S76-S76

2022

Volltextzugriff (PDF)

136 Impact of the STOP2 trial on pulmonary exacerbation treatment duration at cuystic fibrosis centers across the United States

Journal of cystic fibrosis, 2024-09, Vol.23, p.S74-S75

2024

Volltextzugriff (PDF)

138 Impact of pulmonary exacerbations (PEx) on health-related quality of life (HRQoL) assessed by the Cystic Fibrosis Questionnaire-Revised (CFQ-R) in TRAFFIC and TRANSPORT

Journal of cystic fibrosis, 2016-06, Vol.15, p.S86-S86

2016

Volltextzugriff (PDF)

139 Persons with worse psychological status at STOP-2 enrollment have greater incidence of adverse experiences

Journal of cystic fibrosis, 2024-09, Vol.23, p.S77-S77

2024

Volltextzugriff (PDF)

14 Spontaneous changes to airway microbiology after initiation of elexacaftor-tezacaftor-ivacaftor in people with advanced cystic fibrosis lung disease

Journal of cystic fibrosis, 2023-10, Vol.22, p.S9-S9

2023

Volltextzugriff (PDF)

153 Early change in forced vital capacity as a determinant of outcome in pulmonary exacerbations of cystic fibrosis

Journal of cystic fibrosis, 2024-09, Vol.23, p.S85-S85

2024

Volltextzugriff (PDF)

153: Site of intravenous antimicrobial treatment of pulmonary exacerbations in the STOP2 study: Home versus hospital

Journal of cystic fibrosis, 2021-11, Vol.20, p.S76-S77

2021

Volltextzugriff (PDF)

157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response

Journal of cystic fibrosis, 2021-11, Vol.20, p.S78-S78

2021

Volltextzugriff (PDF)

169: Effect of pregnancy on lung function: Impact of CFTR modulators

Journal of cystic fibrosis, 2021-11, Vol.20, p.S83-S84

2021

Volltextzugriff (PDF)

188 Standardized treatment of pulmonary exacerbations (STOP) study: Clinical presentations of pulmonary exacerbations

Journal of cystic fibrosis, 2015-06, Vol.14, p.S106-S106

2015

Volltextzugriff (PDF)

189 Standardized treatment of pulmonary exacerbation (STOP) study: Symptomatic treatment response

Journal of cystic fibrosis, 2015-06, Vol.14, p.S106-S106

2015

Volltextzugriff (PDF)

241: The impact of implementing specialty pharmacy services within a cystic fibrosis clinic

Journal of cystic fibrosis, 2021-11, Vol.20, p.S117

2021

Volltextzugriff (PDF)

28 A multi-center study of peripherally inserted central venous catheters: Predictors of difficult line insertion, malfunction, and soft tissue injury

Journal of cystic fibrosis, 2022-10, Vol.21, p.S17-S18

2022

Volltextzugriff (PDF)

303: Anxiety and depression screening: A five-year experience in a southeastern pediatric CF program

Journal of cystic fibrosis, 2021-11, Vol.20, p.S146

2021

Volltextzugriff (PDF)

37 Microbiologic changes observed over 6 months in a randomized, open-label comparison of inhaled levofloxacin and inhaled tobramycin in persons with cystic fibrosis and chronic P. aeruginosa (Pa) airway infection

Journal of cystic fibrosis, 2016-06, Vol.15, p.S60-S61

2016

Volltextzugriff (PDF)

38 History of pulmonary exacerbations (PEx) as a predictor of response to nebulized levofloxacin compared with nebulized tobramycin

Journal of cystic fibrosis, 2016-06, Vol.15, p.S61-S61

2016

Volltextzugriff (PDF)

4 Role of hyperglycemia in cystic fibrosis pulmonary exacerbations

Journal of cystic fibrosis, 2022-10, Vol.21, p.S3-S3

2022

Volltextzugriff (PDF)

5 Nontuberculous mycobacterial infection as a barrier to lung transplantation in people with cystic fibrosis

Journal of cystic fibrosis, 2023-10, Vol.22, p.S3-S4

2023

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(130)

Publikationsform

Artikel
(141)
Berichte
(1)

Sprache

Englisch
(142)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Humans
(61)
Life Sciences & Biomedicine
(60)
Respiratory System
(44)
Cystic Fibrosis
(36)
Female
(33)
Adult
(32)
Biological And Medical Sciences
(32)
Medical Sciences
(31)
Male
(29)
Pulmonary/respiratory
(26)
General & Internal Medicine
(23)
Critical Care Medicine
(19)
Cystic Fibrosis - Complications
(15)
Cystic Fibrosis - Drug Therapy
(15)
Cystic Fibrosis - Therapy
(15)
Adolescent
(13)
Child
(13)
Middle Aged
(12)
Anti-Bacterial Agents - Therapeutic Use
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

102: Parental newborn screening experience at a southeastern CF center

104 Effect of acute systemic corticosteroids on clinical outcomes in cystic fibrosis pulmonary exacerbations

11 Examining antibiotic regimen spectrum and clinical outcomes of pulmonary exacerbation treatment

115 Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis – Cochrane review

117 Safety profile of levofloxacin inhalation solution from 3 controlled cystic fibrosis clinical trials

A 12-Year-Old Girl With Dyspnea and a Normal Chest Radiographic Finding

A 12-year-old girl with dyspnea and a normal chest radiographic finding. Hypersensitivity pneumonitis

128 Sex-based differences in cystic fibrosis pulmonary exacerbations: Subanalysis of the Standardized Treatment of Pulmonary Exacerbations-2 cohort

136 Impact of the STOP2 trial on pulmonary exacerbation treatment duration at cuystic fibrosis centers across the United States

138 Impact of pulmonary exacerbations (PEx) on health-related quality of life (HRQoL) assessed by the Cystic Fibrosis Questionnaire-Revised (CFQ-R) in TRAFFIC and TRANSPORT

139 Persons with worse psychological status at STOP-2 enrollment have greater incidence of adverse experiences

14 Spontaneous changes to airway microbiology after initiation of elexacaftor-tezacaftor-ivacaftor in people with advanced cystic fibrosis lung disease

153 Early change in forced vital capacity as a determinant of outcome in pulmonary exacerbations of cystic fibrosis

153: Site of intravenous antimicrobial treatment of pulmonary exacerbations in the STOP2 study: Home versus hospital

157: C-reactive protein (CRP) as a biomarker of exacerbation presentation and treatment response

169: Effect of pregnancy on lung function: Impact of CFTR modulators

188 Standardized treatment of pulmonary exacerbations (STOP) study: Clinical presentations of pulmonary exacerbations

189 Standardized treatment of pulmonary exacerbation (STOP) study: Symptomatic treatment response

241: The impact of implementing specialty pharmacy services within a cystic fibrosis clinic

28 A multi-center study of peripherally inserted central venous catheters: Predictors of difficult line insertion, malfunction, and soft tissue injury

303: Anxiety and depression screening: A five-year experience in a southeastern pediatric CF program

37 Microbiologic changes observed over 6 months in a randomized, open-label comparison of inhaled levofloxacin and inhaled tobramycin in persons with cystic fibrosis and chronic P. aeruginosa (Pa) airway infection

38 History of pulmonary exacerbations (PEx) as a predictor of response to nebulized levofloxacin compared with nebulized tobramycin

4 Role of hyperglycemia in cystic fibrosis pulmonary exacerbations

5 Nontuberculous mycobacterial infection as a barrier to lung transplantation in people with cystic fibrosis

Suchergebnisse filtern